TGI
TRV GP III Portfolio holdings
AUM
$6.14M
This Quarter Return
+22.62%
1 Year Return
+45.44%
3 Year Return
+169.05%
5 Year Return
+771.75%
10 Year Return
–
AUM
$369M
AUM Growth
+$369M
(-7.8%)
Cap. Flow
-$7.01M
Cap. Flow
% of AUM
-1.9%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Nurix Therapeutics
NRIX
|
$7.01M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.24B
| $141M | 38.24% |
5,524,031
| – | – |
|
2
Fulcrum Therapeutics
FULC
$353M
| $93.7M | 25.43% |
3,962,202
| – | – |
|
3
Voyager Therapeutics
VYGR
$201M
| $48.7M | 13.21% |
6,391,176
| – | – |
|
4
Pliant Therapeutics
PLRX
$98.2M
| $40.9M | 11.11% |
5,839,160
| – | – |
|
|
5
Nurix Therapeutics
NRIX
$713M
| $26.9M | 7.31% |
1,922,549
-500,000
| -21% | -$7.01M |
|
|
DBTX
6
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
| $9.55M | 2.59% |
3,139,685
| – | – |
|
|
JNCE
7
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $7.8M | 2.12% |
1,148,780
| – | – |
|